Your session is about to expire
← Back to Search
Cognitive Behavioural Therapy for Perimenopause
Study Summary
This trial is testing a new CBT protocol specifically designed to help with sexual concerns during perimenopause. The aim is to see if it improves sexual satisfaction and reduces distress.
- Perimenopause
- Sexual Dysfunction
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is recruitment still ongoing for this research endeavor?
"Per the information on clinicaltrials.gov, this experiment is recruiting participants right now. It was first listed in January of 2021 and has received a recent update as of August 2022."
Does this trial include geriatric patients?
"This trial is inviting candidates aged 40-60 to participate."
To what capacity has the participant recruitment for this research reached?
"Affirmative, the information hosted on clinicaltrials.gov displays that this study is actively attempting to recruit patients. This medical trial was initially posted in January 2021 and last modified in August 2022; it calls for 62 applicants from a single location."
Who is eligible to become involved with this clinical experiment?
"This medical research is seeking to enlist 62 volunteers, 40-60 years of age, who are currently experiencing perimenopause. Additional criteria for selection include a cut off score of 26 or less on the Female Sexual Functioning Index (Wiegel et al., 2005), and an absence from psychological intervention in relation to sexual dysfunction within half a year."
What are the chief aims of this research endeavor?
"This 6-week clinical trial will use the Female Sexual Desire Questionnaire (FSDQ) to evaluate its primary goal. As secondary measures, The Couples Satisfaction Index (CSI), The Hot Flash Related Daily Interference Scale (HFRDIS), and The Hamilton Anxiety Scale (HAM-A) are employed. Scoring on the CSI varies from 0 to 81, with greater values signifying a heightened level of contentment in relationships; HFRDIS scores range from 0 to 24 and reflect how vasomotor symptoms interfere with day-to-day life while HAM-A is graded on a scale between 0 and 56,"
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger